JNJ
$145.27
Revenue | $22471Mn |
Net Profits | $2694Mn |
Net Profit Margins | 11.99% |
Johnson & Johnson’s revenue jumped 5.25% since last year same period to $22471Mn in the Q3 2024. On a quarterly growth basis, Johnson & Johnson has generated 0.11% jump in its revenue since last 3-months.
Johnson & Johnson’s net profit fell -89.65% since last year same period to $2694Mn in the Q3 2024. On a quarterly growth basis, Johnson & Johnson has generated -42.51% fall in its net profits since last 3-months.
Johnson & Johnson’s net profit margin fell -90.17% since last year same period to 11.99% in the Q3 2024. On a quarterly growth basis, Johnson & Johnson has generated -42.57% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.21 |
EPS Estimate Current Year | 2.21 |
Johnson & Johnson’s earning per share (EPS) estimates for the current quarter stand at 2.21 - a -18.15% fall from last quarter’s estimates.
Johnson & Johnson’s earning per share (EPS) estimates for the current year stand at 2.21.
Earning Per Share (EPS) | 2.42 |
Dividend Per Share (DPS) | 1.24 |
Johnson & Johnson’s earning per share (EPS) fell -9.02% since last year same period to 2.42 in the Q3 2024. This indicates that the Johnson & Johnson has generated -9.02% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Johnson & Johnson declared 1.24 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-01 | 2.64 | 2.71 | 2.65% |
2024-10-23 | 2.21 | 2.42 | 9.5% |
2024-07-25 | 2.7 | 2.82 | 4.44% |